Cargando…
Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study
BACKGROUND: On March 11, 2020, the World Health Organization (WHO) officially announced that the coronavirus disease 2019 (COVID-19) had reached global pandemic status. Current studies have found that angiotensin-converting enzyme 2 (ACE2) is a cell surface receptor of the novel coronavirus that pla...
Autores principales: | Han, Tao, Kang, Jing, Li, Gao, Ge, Jing, Gu, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576005/ https://www.ncbi.nlm.nih.gov/pubmed/33145296 http://dx.doi.org/10.21037/atm-20-4281 |
Ejemplares similares
-
ACE2 in the Gut: The Center of the 2019-nCoV Infected Pathology
por: Guo, Yuexin, et al.
Publicado: (2021) -
Corrigendum: ACE2 in the gut: The center of the 2019-nCoV infected pathology
por: Guo, Yuexin, et al.
Publicado: (2022) -
Advances in research on ACE2 as a receptor for 2019-nCoV
por: Wu, Jie, et al.
Publicado: (2020) -
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
por: Xu, Hao, et al.
Publicado: (2020) -
Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus
por: Wang, Nan, et al.
Publicado: (2020)